Comments
Biocon, Bristol-Myers in deal for oral insulin drug
16.11.2012. | MUMBAI (Reuters) - Biocon Ltd, India's top-listed biotechnology company, said it signed an agreement with Bristol-Myers Squibb Co under which the U.S. drugmaker will have the option to get the worldwide license to its oral insulin drug program....
